231 related articles for article (PubMed ID: 24066967)
21. Enzyme-Driven Chemo-and Radiation-Therapy with 12 Pyrimidine Nucleoside Analogs Not Yet in the Clinic.
Greer S; Han T; Dieguez C; McLean N; Saer R; Reis I; Levi J; Marquez VE
Anticancer Agents Med Chem; 2017; 17(2):250-264. PubMed ID: 27745548
[TBL] [Abstract][Full Text] [Related]
22. Comparison of the substrate specificities of human thymidine kinase 1 and 2 and deoxycytidine kinase toward antiviral and cytostatic nucleoside analogs.
Eriksson S; Kierdaszuk B; Munch-Petersen B; Oberg B; Johansson NG
Biochem Biophys Res Commun; 1991 Apr; 176(2):586-92. PubMed ID: 2025274
[TBL] [Abstract][Full Text] [Related]
23. Nucleotide specificity of human deoxycytidine kinase.
Shewach DS; Reynolds KK; Hertel L
Mol Pharmacol; 1992 Sep; 42(3):518-24. PubMed ID: 1406603
[TBL] [Abstract][Full Text] [Related]
24. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
[TBL] [Abstract][Full Text] [Related]
25. Protein phosphatase 2A regulates deoxycytidine kinase activity via Ser-74 dephosphorylation.
Amsailale R; Beyaert M; Smal C; Janssens V; Van Den Neste E; Bontemps F
FEBS Lett; 2014 Mar; 588(5):727-32. PubMed ID: 24462681
[TBL] [Abstract][Full Text] [Related]
26. Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase?
Bergman AM; Cristalli G; Vittori S; Wang J; Eriksson S; Peters GJ
Nucleosides Nucleotides; 1999; 18(4-5):897-8. PubMed ID: 10432706
[TBL] [Abstract][Full Text] [Related]
27. Bystander effects of nucleoside analogs phosphorylated in the cytosol or mitochondria.
Sanda A; Zhu C; Johansson M; Karlsson A
Biochem Biophys Res Commun; 2001 Oct; 287(5):1163-6. PubMed ID: 11587545
[TBL] [Abstract][Full Text] [Related]
28. Incorporation of nucleoside analogs into nuclear or mitochondrial DNA is determined by the intracellular phosphorylation site.
Zhu C; Johansson M; Karlsson A
J Biol Chem; 2000 Sep; 275(35):26727-31. PubMed ID: 10827186
[TBL] [Abstract][Full Text] [Related]
29. Phosphorylation of 4'-thio-beta-D-arabinofuranosylcytosine and its analogs by human deoxycytidine kinase.
Someya H; Shaddix SC; Tiwari KN; Secrist JA; Parker WB
J Pharmacol Exp Ther; 2003 Mar; 304(3):1314-22. PubMed ID: 12604712
[TBL] [Abstract][Full Text] [Related]
30. Molecular Imaging of Deoxycytidine Kinase Activity Using Deoxycytidine-Enhanced CEST MRI.
Han Z; Li Y; Zhang J; Liu J; Chen C; van Zijl PC; Liu G
Cancer Res; 2019 May; 79(10):2775-2783. PubMed ID: 30940660
[TBL] [Abstract][Full Text] [Related]
31. Fluorescence energy transfer studies of human deoxycytidine kinase: role of cysteine 185 in the conformational changes that occur upon substrate binding.
Mani RS; Usova EV; Cass CE; Eriksson S
Biochemistry; 2006 Mar; 45(11):3534-41. PubMed ID: 16533034
[TBL] [Abstract][Full Text] [Related]
32. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
Hapke DM; Stegmann AP; Mitchell BS
Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
[TBL] [Abstract][Full Text] [Related]
33. Deoxycytidine kinase modulates the impact of the ABC transporter ABCG2 on clofarabine cytotoxicity.
Nagai S; Takenaka K; Nachagari D; Rose C; Domoney K; Sun D; Sparreboom A; Schuetz JD
Cancer Res; 2011 Mar; 71(5):1781-91. PubMed ID: 21245102
[TBL] [Abstract][Full Text] [Related]
34. Selective activation of deoxycytidine kinase by thymidine-5'-thiosulphate and release by deoxycytidine in human lymphocytes.
Keszler G; Szikla K; Kazimierczuk Z; Spasokoukotskaja T; Sasvari-Szekely M; Staub M
Biochem Pharmacol; 2003 Feb; 65(4):563-71. PubMed ID: 12566083
[TBL] [Abstract][Full Text] [Related]
35. Substrate/inhibitor properties of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2) towards the sugar moiety of nucleosides, including O'-alkyl analogues.
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Nucleosides Nucleotides; 1999 Aug; 18(8):1883-903. PubMed ID: 10478487
[TBL] [Abstract][Full Text] [Related]
36. Activation of deoxycytidine kinase by gamma-irradiation and inactivation by hyperosmotic shock in human lymphocytes.
Csapo Z; Keszler G; Safrany G; Spasokoukotskaja T; Talianidis I; Staub M; Sasvari-Szekely M
Biochem Pharmacol; 2003 Jun; 65(12):2031-9. PubMed ID: 12787883
[TBL] [Abstract][Full Text] [Related]
37. The sugar ring of the nucleoside is required for productive substrate positioning in the active site of human deoxycytidine kinase (dCK): implications for the development of dCK-activated acyclic guanine analogues.
Hazra S; Konrad M; Lavie A
J Med Chem; 2010 Aug; 53(15):5792-800. PubMed ID: 20684612
[TBL] [Abstract][Full Text] [Related]
38. Activation of deoxycytidine kinase by UV-C-irradiation in chronic lymphocytic leukemia B-lymphocytes.
Van Den Neste E; Smal C; Cardoen S; Delacauw A; Frankard J; Ferrant A; Van den Berghe G; Bontemps F
Biochem Pharmacol; 2003 Feb; 65(4):573-80. PubMed ID: 12566084
[TBL] [Abstract][Full Text] [Related]
39. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
[TBL] [Abstract][Full Text] [Related]
40. Substrate/inhibitor specificities of human deoxycytidine kinase (dCK) and thymidine kinases (TK1 and TK2).
Kierdaszuk B; Krawiec K; Kazimierczuk Z; Jacobsson U; Johansson NG; Munch-Petersen B; Eriksson S; Shugar D
Adv Exp Med Biol; 1998; 431():623-7. PubMed ID: 9598140
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]